Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)

Condition: Primary Biliary Cirrhosis (PBC)Interventions: Drug: Placebo Comparator; Drug: Experimental: MBX-8025 50 mg; Drug: Experimental: MBX-8025 200 mgSponsors: CymaBay Therapeutics, Inc.; PRA Health SciencesRecruiting - verified November 2015

http://clinicaltrials.gov/ct2/show/NCT02609048?lup_s=10%2F22%2F2015&lup_d=30

Source: ClinicalTrials.gov - November 13, 2015 Category: Research Source Type: clinical trials

More News: Cirrhosis | Primary Biliary Cirrhosis | Research | Study